ERAS Stock Analysis: Buy, Sell, or Hold?

ERAS - Erasca, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$15.21
0.13 (0.86%) ▲
5d: +5.41%
30d: +31.06%
90d: +6.22%
HOLD
MODERATE Confidence
Protect Your ERAS Gains
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Aug 11, 2026
Smart Money Distribution

None View Scanner →

Strength: 7.7/10

Get Alerted When ERAS Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: ERAS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: ERAS is currently trading at $15.21, which is considered extended relative to its 30-day fair value range of $11.41 to $14.22.

Technical Outlook: Technically, ERAS is showing sideways momentum. The price is approaching resistance at $15.19. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.

Market Sentiment: ERAS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $21.00 (+39.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position EXTENDED
Historical Trading Range $11.41 - $14.22
Company Quality Score 54/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 57.9%

Protect Your Profits

Holding ERAS? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • BEARISH: Price extended above range (+7.0% above its trading range)
  • BULLISH: Strong technical setup (60/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 39.3% below Wall St target ($21.00)

Trading Range Analysis

30-Day Trading Range $11.41 - $14.22
Current vs Trading Range EXTENDED

Support & Resistance Levels

Support Level $12.26
Resistance Level $15.19
Current Trend Sideways
Technical data as of Jun 22, 2026

Fundamental Context

Forward P/E (Next Year Est.) -26.24
Wall Street Target $21.00 (+39.3%)
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: June 23, 2026 12:55 PM ET
Data refreshes hourly during market hours. Next update: 1:55 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Ebun Garner SELL 80000 shares 2026-04-01
Shannon Morris SELL 20000 shares 2026-03-04
Ebun Garner SELL 120000 shares 2026-01-07

Unlock Insider Activity

See real-time buying/selling by company executives for ERAS.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
NTLA
Intellia Therapeutics Inc
STRONG BUY
29 analysts
$27 56 HOLD
ARGX
argenx NV ADR
STRONG BUY
22 analysts
$1022 64 BUY
ONC
BeiGene, Ltd.
STRONG BUY
24 analysts
$412 53 HOLD
INSM
Insmed Inc
STRONG BUY
21 analysts
$197 56 HOLD
ACLX
Arcellx Inc
STRONG BUY
18 analysts
$113 57 HOLD

Advanced ERAS Option Strategies

Professional options setups generated by AI based on today's ERAS price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for ERAS

ERAS Technical Chart ERAS Price Prediction ERAS Earnings Date ERAS Investment Advisor ERAS Fair Price Analyzer ERAS Options Advisor ERAS Options Chain ERAS Options Analysis ERAS Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals